Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Net Sales	$ 7,982.2	$ 7,932.9	$ 7,803.3
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 2,252.6	$ 2,271.9	$ 2,132.9
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 584.3	$ 595.9	$ 603.9
Research and development	449.3	391.7	369.9
Selling, general and administrative	3,343.8	3,379.3	3,104.7
Goodwill and intangible asset impairment	70.1	979.7	331.5
Quality remediation	82.4	146.9	181.3
Restructuring and other cost reduction initiatives	50.0	34.2	17.6
Acquisition, integration and related	12.2	99.5	262.2
Operating expenses	6,844.7	7,899.1	7,004.0
Operating Profit	1,137.5	33.8	799.3
Other expense, net	(4.8)	(15.6)	(9.4)
Interest expense, net	(226.9)	(289.3)	(325.3)
Earnings (loss) before income taxes	905.8	(271.1)	464.6
(Benefit) provision for income taxes	(225.7)	108.2	(1,348.8)
Net Earnings (Loss)	1,131.5	(379.3)	1,813.4
Less: Net loss attributable to noncontrolling interest	(0.1)	(0.1)	(0.4)
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	$ 1,131.6	$ (379.2)	$ 1,813.8
Earnings (Loss) Per Common Share - Basic	$ 5.52	$ (1.86)	$ 8.98
Earnings (Loss) Per Common Share - Diluted	$ 5.47	$ (1.86)	$ 8.90
Weighted Average Common Shares Outstanding
Basic	205.1	203.5	201.9
Diluted	206.7	203.5	203.7